½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1383330

ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå ¿¹Ãø(-2030³â) : ¼öÁغ°, À¯Çüº°, Àü°³º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®

Healthcare Interoperability Solutions Market Forecasts to 2030 - Global Analysis By Level (Foundational, Semantic, Structural and Other Levels), Type, Deployment, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀåÀº 2023³â 40¾ï ´Þ·¯·Î ¿¹Ãø ±â°£ µ¿¾È 16.9%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 119¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°³ÀÎ ¹× Áö¿ª»çȸÀÇ °Ç°­ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ÀÇ·áÀÇ »óÈ£¿î¿ë¼ºÀº ½Å¼ÓÇÏ°í ¾ÈÀüÇÑ Á¢±ÙÀ» ÅëÇÑ ÀüÀÚ ÀÇ·á µ¥ÀÌÅÍÀÇ ÅëÇÕ ¹× È°¿ëÀ» ÀǹÌÇÕ´Ï´Ù. ÇöÀç ÀÇ·á ºÐ¾ß´Â ÀÇ·á ½Ã¼³ÀÇ ¼öÁØ Çâ»ó°ú ¿î¿µ È¿À²¼º °³¼±, ´Ù¾çÇÑ ÀÇ·á ÀýÂ÷ Áß ¹ß»ýÇÏ´Â ÀÇ·á ½Ç¼ö¸¦ ÁÙÀÌ°í ¿î¿µ ºñ¿ëÀ» Àý°¨ÇÏ´Â µ¥ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº µÎ °³ ÀÌ»óÀÇ ½Ã½ºÅÛ °£ÀÇ °Ç°­ µ¥ÀÌÅÍ ±³È¯ ¹× ÈÄ¼Ó µ¥ÀÌÅÍ È°¿ëÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

µ¶ÀÏ ¿¬¹æÅë°èû(Destatis)ÀÇ 2022³â 6¿ù º¸°í¼­¿¡ µû¸£¸é µ¶ÀÏÀÇ ÀÇ·áºñ ÁöÃâÀº Çظ¶´Ù Áõ°¡ÇÏ¿© 2020³â¿¡´Â 4,410¾ï À¯·Î¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áõ°¡ÇÏ´Â ÀÇ·á µ¥ÀÌÅÍ·®

ÀüÀÚ ÀÇ·á ±â·Ï(EHR), ÀÇ·á ¿µ»ó, ÀÓ»ó ±â·Ï, ȯÀÚ ±â·ÏÀº ÀÇ·á ½Ã½ºÅÛ¿¡¼­ »ý¼ºµÇ´Â ¼ö¸¹Àº µ¥ÀÌÅÍ Áß ÀϺο¡ ºÒ°úÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µ¥ÀÌÅ͸¦ ÀÇ·á±â°ü, ½Ã½ºÅÛ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£¿¡ È¿°úÀûÀÌ°í ¾ÈÀüÇÏ°Ô ÀúÀåÇÏ°í °øÀ¯Çϱâ À§Çؼ­´Â »óÈ£¿î¿ë¼ºÀ» À§ÇÑ ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â Á¾ÇÕÀûÀΠȯÀÚ ±â·ÏÀ» È®º¸ÇÏ°í, Çö¸íÇÑ ÀÓ»óÀû ÆÇ´ÜÀ» ³»¸®°í, ÀÇ·á ½Ç¼ö¸¦ ÁÙÀÌ°í, ÀÇ·á Çù·ÂÀ» °­È­Çϱâ À§ÇØ È¯ÀÚ µ¥ÀÌÅ͸¦ ½±°Ô ±³È¯ÇÏ°í ÅëÇÕÇÒ ¼ö ÀÖ¾î¾ß ÇÕ´Ï´Ù.

µ¥ÀÌÅÍ º¸¾È ¹× ÇÁ¶óÀ̹ö½Ã °ü·Ã ¹®Á¦

¸¹Àº ÀÇ·á Á¶Á÷°ú ½Ã½ºÅÛÀ» ÅëÇØ È¯ÀÚÀÇ °³ÀÎ µ¥ÀÌÅÍ°¡ °øÀ¯µÇ¸é¼­ µ¥ÀÌÅÍ º¸¾È°ú ȯÀÚ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á°¡ Á¦±âµÇ°í ÀÖ½À´Ï´Ù. °³ÀÎ Á¤º¸ µµ³­, »ç±â, ȯÀÚ ½Å·Ú »ó½ÇÀº ÀÇ·á µ¥ÀÌÅÍ À¯Ãâ·Î ÀÎÇÑ ½É°¢ÇÑ °á°ú Áß ÀϺο¡ ºÒ°úÇÕ´Ï´Ù. ÀÇ·á ±â¾÷Àº ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ °í±Þ ¾×¼¼½º Á¦¾î, ¾Ïȣȭ ±â¼ú ¹× »çÀ̹ö º¸¾È Á¶Ä¡¿¡ ¸¹Àº ÅõÀÚ¸¦ ÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ EUÀÇ GDPR, ¹Ì±¹ÀÇ HIPAA¿Í °°Àº ¾ö°ÝÇÑ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹ý±Ô¸¦ ÁؼöÇØ¾ß ÇÕ´Ï´Ù.

ȯÀÚ °ü¸® ¹× Ä¡·á °á°ú °³¼±

ÀÇ·áÁøÀº »óÈ£¿î¿ë¼º ¼Ö·ç¼ÇÀ» ÅëÇØ ÀüÀÚ ÀÇ·á ±â·Ï, Áø´Ü °á°ú, Ä¡·á ÀÌ·Â µî ȯÀÚ µ¥ÀÌÅ͸¦ ½±°Ô °øÀ¯ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·áÁøÀº »ó¼¼ÇÑ È¯ÀÚ µ¥ÀÌÅÍ¿¡ Áï°¢ÀûÀ¸·Î Á¢±ÙÇÒ ¼ö ÀÖ¾î ´õ ³ªÀº ÀÓ»óÀû ÆÇ´ÜÀ» ³»¸± ¼ö ÀÖ¾î ȯÀÚ Ä¡·áÀÇ ÁúÀ» Çâ»ó½ÃÅ°°í ÁÁÀº °á°ú¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »óÈ£ ¿î¿ë °¡´ÉÇÑ ½Ã½ºÅÛÀº ÀÇ·á ½Ç¼ö¸¦ ÁÙÀÌ°í, ºÒÇÊ¿äÇÑ °Ë»ç¸¦ ¹æÁöÇϸç, Á¤È®ÇÏ°í ½Å¼ÓÇÑ Ä¡·á¸¦ º¸ÀåÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, ÀÌ ¸ðµç °ÍÀÌ ÀϹÝÀûÀÎ ÀÇ·á ¼öÁØÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ Ä¡·á Á¶Á¤ °úÁ¤À» °£¼ÒÈ­ÇÏ¿© º¸´Ù ȯÀÚ Áß½ÉÀÇ ÀÇ·á Á¢±Ù ¹æ½ÄÀ» ½ÇÇöÇÒ ¼ö ÀÖ½À´Ï´Ù.

³ôÀº ºñ¿ë

»óÈ£¿î¿ëÀÌ °¡´ÉÇÑ ½Ã½ºÅÛÀº ÀÇ·á Ä¡·á¸¦ º¸´Ù È¿À²ÀûÀ¸·Î °ü¸®ÇÏ°í ȯÀÚ Ä¡·á¸¦ °³¼±ÇÒ ¼ö ÀÖÁö¸¸, µµÀÔ¿¡ ¸¹Àº Ãʱ⠺ñ¿ëÀÌ ¼Ò¿äµÉ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ±â¾÷µéÀº Á÷¿ø ±³À°, »óÈ£¿î¿ë¼º ¼ÒÇÁÆ®¿þ¾î ±¸¸Å, °¢Á¾ ½Ã½ºÅÛ ÅëÇÕ, ±âÁ¸ IT ÀÎÇÁ¶óÀÇ Çö´ëÈ­ µîÀ» À§ÇØ º°µµÀÇ ÀÚ±ÝÀ» ¸¶·ÃÇØ¾ß ÇÕ´Ï´Ù. ±×·¯³ª °æ¿µ ÀÚ¿øÀÌ ÇÑÁ¤µÈ ¼Ò±Ô¸ð ÀÇ·á ½Ã¼³°ú ±×·ìÀº ÀÌ·¯ÇÑ ºñ¿ëÀÇ ¿µÇâÀ» ƯÈ÷ ¸¹ÀÌ ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ:

COVID-19 ȯÀÚÀÇ ¿¹»óÄ¡ ¸øÇÑ Áõ°¡·Î ÀÎÇØ COVID-19 ÆÒµ¥¹ÍÀº ¼¼°è °æÁ¦¿Í ÀÇ·á ½Ã½ºÅÛ¿¡ Å« ¿µÇâÀ» ¹ÌÃƽÀ´Ï´Ù. ´Ù¾çÇÑ ÀÇ·á ¹®Á¦¸¦ °¡Áø COVID-19 ȯÀÚÀÇ ¿¹»óÄ¡ ¸øÇÑ ±ÞÁõÀº ¸ðµç ÀÇ·á ½Ã¼³ÀÇ Á¤»óÀûÀÎ ¿î¿µÀ» ¹æÇØÇÏ°í ÀÇ·á »óÈ£ ¿î¿ë ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½ÃÄ×½À´Ï´Ù. Àü·Ê ¾ø´Â ¼¼°è °øÁߺ¸°Ç À§ÇùÀÎ COVID-19´Â ¹é½Å ¹× Ç×¹ÙÀÌ·¯½ºÁ¦ ¿¬±¸°³¹ßÀ» À§ÇÑ ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ½Ã¸Çƽ ºÎ¹®ÀÌ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»ó

¿¹Ãø ±â°£ µ¿¾È ½Ã¸Çƽ ºÐ¾ß°¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÇöÀç ½ÃÀå¿¡ ³ª¿Í ÀÖ´Â »óÈ£¿î¿ë¼º ¹æ¹ý Áß °¡Àå ½Å·ÚÇÒ ¼ö ÀÖ´Â ½Ã¸Çƽ »óÈ£¿î¿ë¼ºÀº µÎ °³ ÀÌ»óÀÇ ½Ã½ºÅÛ °£ Á¤º¸ Àü´ÞÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¼­·Î ´Ù¸¥ EHR ¹× ±âŸ ½Ã½ºÅÛÀ» ÅëÇØ ½Ã¸Çƽ »óÈ£¿î¿ë¼ºÀº ´Ù¾çÇÑ ±ÇÇÑÀÌ ÀÖ´Â ´ç»çÀÚ ¹× ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ È¯ÀÚ µ¥ÀÌÅÍÀÇ ÀüÀÚÀû ±³È¯À» ¿ëÀÌÇÏ°Ô ÇÏ¿© ÀÇ·á Á¦°øÀÇ È¿°ú, È¿À²¼º ¹× ¾ÈÀü¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ, ÀÇ·á Á¤º¸ÀÇ Àǹ̸¦ ÀÌÇØÇÏ°í Á¤È®ÇÏ°Ô ÆÇ´ÜÇÏ´Â ´É·ÂÀ¸·Î ±¸¼ºµÈ ½Ã¸Çƽ ºÎ¹®Àº ÀÇ·á µ¥ÀÌÅÍ ±³È¯ÀÇ Áß¿äÇÑ Ãø¸éÀÔ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â ÀÇ·á ÁöºÒÀÎ ºÎ¹®

¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÎ¹®Àº ÀÇ·á ÁöºÒÀÚ ºÎ¹®ÀÔ´Ï´Ù. º¸Çè»ç ¹× Á¤ºÎ ±â°ü°ú °°Àº ÀÇ·á ÁöºÒÀÚ´Â º¸Çè±Ý û±¸ ó¸® ¼Óµµ¸¦ ³ôÀÌ°í, ÁöºÒ ÀýÂ÷¸¦ °³¼±Çϸç, ÀÇ·á ºñ¿ëÀÇ Àü¹ÝÀûÀÎ °ü¸®¸¦ °³¼±Çϱâ À§ÇØ »óÈ£ ¿î¿ë °¡´ÉÇÑ ¼Ö·ç¼ÇÀ» »ç¿ëÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·áºñ´Â Áõ°¡ÇÏ´Â ¹Ý¸é °ü¸® ºñ¿ëÀº °¨¼ÒÇϱ⠶§¹®¿¡ ÁöºÒÀÚ´Â »óÈ£¿î¿ë¼ºÀ» È°¿ëÇÏ¿© º¸´Ù È¿°úÀûÀÎ ±ÝÀ¶ °Å·¡¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿ÍÀÇ µ¥ÀÌÅÍ ±³È¯À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª:

¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áÀÇ Áú°ú ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Á¢±Ù¼ºÀÌ ³ô°í È¿°úÀûÀÎ Ä¡·áÀÇ Çʿ伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ÀÌ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ ±Þ¼ÓÇÑ µµ½ÃÈ­¿Í °æÁ¦ ¼ºÀåÀ¸·Î ÀÎÇØ ÀÇ·á±â°üÀÇ ¹ßÀüÀÌ ÃËÁøµÇ°í ÀÖÀ¸¸ç, ÷´Ü ÀÇ·á IT ½Ã½ºÅÛÀÇ µµÀÔÀÌ ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

¾Æ½Ã¾ÆÅÂÆò¾çÀº °Å´ëÇÏ°í ´Ù¾çÇÑ Àα¸¿Í ´õ ³ªÀº ÀÇ·á ¼­ºñ½º ¹× ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼öÀͼº ³ôÀº ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ȯÀÚ Ä¡·á¸¦ °³¼±ÇÏ°í, ÀÇ·á ÀýÂ÷¸¦ ü°èÈ­ÇÏ°í, ºñ¿ëÀ» Àý°¨Çϱâ À§ÇØ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¢±¹ Á¤ºÎ´Â ÀÇ·á ÀÎÇÁ¶ó, µðÁöÅÐ °Ç°­ ÇÁ·Î±×·¥ ¹× »óÈ£ ¿î¿ë °¡´ÉÇÑ ±â¼ú »ç¿ë¿¡ ´ëÇÑ ÅõÀÚ¸¦ È®´ëÇÏ°í ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º Á¦°ø:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÇü ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù:

  • ȸ»ç ÇÁ·ÎÇÊ
    • Ãß°¡ ½ÃÀå ÁøÀÔ ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, CAGR(Âü°í: Ÿ´ç¼º °ËÅä¿¡ µû¸¥ °ÍÀÓ)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù¹ý
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼­·Ð
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå : ·¹º§º°

  • ¼­·Ð
  • ±âÃÊÀû
  • ½Ã¸àƽ
  • ±¸Á¶Àû
  • ±âŸ ·¹º§

Á¦6Àå ¼¼°èÀÇ ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå : À¯Çüº°

  • ¼­·Ð
  • ¼Ö·ç¼Ç
  • ¼­ºñ½º
  • ±âŸ À¯Çü

Á¦7Àå ¼¼°èÀÇ ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå : Àü°³º°

  • ¼­·Ð
  • ¿ÂÇÁ·¹¹Ì½º
  • Ŭ¶ó¿ìµå ±â¹Ý

Á¦8Àå ¼¼°èÀÇ ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • ÀÇ·á ÁöºÒÀÚ
  • ¾à±¹
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦9Àå ¼¼°èÀÇ ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå : Áö¿ªº°

  • ¼­·Ð
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîƼ³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ °³¿ä

  • International Business Machines Corporation(IBM)
  • Orion Health Group Limited
  • Virtusa Corpopration
  • Jitterbit
  • Koch Software Investments(Infor Inc.)
  • NextGen Healthcare Inc.
  • EPIC Systems Corporation
  • Oracle Corporation
  • Allscripts Healthcare LLC
  • Koninklijke Philips NV
ksm 23.11.29

According to Stratistics MRC, the Global Healthcare Interoperability Solutions Market is accounted for $4.0 billion in 2023 and is expected to reach $11.9 billion by 2030 growing at a CAGR of 16.9% during the forecast period. In order to improve individual and community health outcomes, interoperability in healthcare refers to the integration and use of electronic health data with prompt and secure access. The healthcare sector is currently heavily focused on improving the standard of healthcare facilities and operating effectiveness, decreasing medical errors that occur during various medical procedures, and reducing operational costs. These solutions enable the interchange of health data between two or more systems and the subsequent use of that data.

According to the June 2022 report of the Federal Statistical Office (Destatis) of Germany, the country's healthcare expenditure is increasing year over year and in 2020 it stood at EUR 441 billion.

Market Dynamics:

Driver:

Increasing volumes of healthcare data

Electronic health records (EHRs), medical images, clinical notes, and patient histories are only a few of the types of data that healthcare systems produce in huge amounts. Solutions for interoperability are necessary to store and share this data effectively, securely, and across institutions, systems, and healthcare providers. Additionally, healthcare providers must be able to effortlessly exchange and integrate patient data in order to obtain comprehensive patient records, make wise clinical judgments, lower medical errors, and enhance care coordination.

Restraint:

Concerns about data security and privacy

Concerns regarding data security and patient privacy are raised by the sharing of private patient data through numerous healthcare organizations and systems. Identity theft, fraud, and breaches of patient confidence are just a few of the serious consequences that can result from healthcare data breaches. Healthcare firms must make significant investments in advanced access controls, encryption technologies, and cybersecurity measures to address these issues. However, they must follow strict data privacy laws like GDPR in the European Union and HIPAA in the United States.

Opportunity:

Better patient care and outcomes

Medical professionals can easily share patient data, such as electronic health records, diagnostic results, and treatment histories, due to interoperability solutions. Healthcare practitioners are granted immediate access to detailed patient data, enabling them to make better-educated clinical decisions that improve patient care and produce favorable results. Furthermore, interoperable systems help to lower medical errors, prevent unnecessary testing, and guarantee accurate and prompt treatment, all of which enhance the general standard of care. The simplified process of care coordination amongst various providers results in a more patient-centric approach to healthcare.

Threat:

High costs

Healthcare treatments will be more efficiently managed and patient care will be improved with interoperable systems, but there may be significant up-front costs involved in implementing them. Healthcare firms need to establish separate funds for staff training, interoperability software purchases, integrating various systems, and modernizing the IT infrastructure that is already in existence. However, smaller healthcare facilities and groups with limited resources may be particularly impacted by these expenses.

COVID-19 Impact:

Due to the unexpected rise in COVID-19 cases, the COVID-19 pandemic had a huge impact on the global economy and healthcare system. The unexpected floods of COVID-19 patients with various medical issues disturbed the regular operation of any healthcare facility, which considerably boosted the demand for healthcare interoperability solutions. An unprecedented worldwide public health threat, the COVID-19 pandemic is expected to positively affect the market for healthcare interoperability solutions for the R&D of vaccines and antiviral drugs.

The semantic segment is expected to be the largest during the forecast period

Semantic segment dominated the largest share over the forecast period. The most reliable interoperability method that is currently on the market, semantic interoperability, allows for the transmission of information between more than two systems. Through possibly different EHRs and other systems, semantic interoperability facilitates the electronic interchange of patient data among various authorized parties and providers in order to increase the effectiveness, efficiency, and safety of healthcare delivery. Additionally, semantic segment which consists of the capacity to comprehend and accurately determine the meaning of healthcare information, is a crucial aspect of healthcare data interchange.

The healthcare payers segment is expected to have the highest CAGR during the forecast period

Healthcare Payers segment is expected to have the highest CAGR during the forecast period. Interoperable solutions are being used by healthcare payers, such as insurance companies and governmental organizations, in an effort to accelerate the processing of insurance claims, improve payment procedures, and improve the overall management of healthcare expenses. Additionally, payers are utilizing interoperability to enable more effective financial transactions and data interchange with healthcare providers as healthcare costs increase while lowering administrative costs.

Region with largest share:

Owing to the increasing awareness of healthcare quality and patient safety and the need for accessible, effective care, Asia Pacific is anticipated to hold the largest share of the market over the projected period. Additionally, rapid urbanization and economic growth in the area are promoting the development of healthcare institutions, which offer the potential for the adoption of cutting-edge health IT systems.

Region with highest CAGR:

Due to the region's huge and diverse population, which is driving up demand for better healthcare services and technologies, Asia Pacific is predicted to have profitable growth. To improve patient care, organize healthcare procedures, and lower costs, governments around Asia-Pacific are expanding their investments in healthcare infrastructure, digital health programs, and the use of interoperable technologies.

Key players in the market

Some of the key players in Healthcare Interoperability Solutions market include: International Business Machines Corporation (IBM), Orion Health Group Limited, Virtusa Corpopration, Jitterbit, Koch Software Investments (Infor Inc.), NextGen Healthcare Inc., EPIC Systems Corporation, Oracle Corporation, Allscripts Healthcare LLC and Koninklijke Philips NV.

Key Developments:

In October 2022, Lyniate (US) partnered with CyncHealth (US) to help healthcare providers and health networks, payers, and public health departments power more meaningful data exchange.

In September 2022, Lyniate (US) partnered with BrightInsight (US) to improve Information Exchange for Regulated Digital Health Solutions Built on the BrightInsight Platform.

In March 2022, eHealth Exchange, the non-profit health information network that connects providers and federal agencies, received a new Innovation Grant program of USD 550,000 to help catalyze new and innovative ways to boost electronic health information exchange or build new technical connectivity tools.

Levels Covered:

  • Foundational
  • Semantic
  • Structural
  • Other Levels

Types Covered:

  • Solutions
  • Services
  • Other Types

Deployments Covered:

  • On-premise
  • Cloud-based

End Users Covered:

  • Healthcare Payers
  • Pharmacies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Healthcare Interoperability Solutions Market, By Level

  • 5.1 Introduction
  • 5.2 Foundational
  • 5.3 Semantic
  • 5.4 Structural
  • 5.5 Other Levels

6 Global Healthcare Interoperability Solutions Market, By Type

  • 6.1 Introduction
  • 6.2 Solutions
  • 6.3 Services
  • 6.4 Other Types

7 Global Healthcare Interoperability Solutions Market, By Deployment

  • 7.1 Introduction
  • 7.2 On-premise
  • 7.3 Cloud-based

8 Global Healthcare Interoperability Solutions Market, By End User

  • 8.1 Introduction
  • 8.2 Healthcare Payers
  • 8.3 Pharmacies
  • 8.4 Other End Users

9 Global Healthcare Interoperability Solutions Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 International Business Machines Corporation (IBM)
  • 11.2 Orion Health Group Limited
  • 11.3 Virtusa Corpopration
  • 11.4 Jitterbit
  • 11.5 Koch Software Investments (Infor Inc.)
  • 11.6 NextGen Healthcare Inc.
  • 11.7 EPIC Systems Corporation
  • 11.8 Oracle Corporation
  • 11.9 Allscripts Healthcare LLC
  • 11.10 Koninklijke Philips NV
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦